Ahuja SK., Manoharan MS., Lee GC., McKinnon LR., Meunier JA., Steri M., Harper N., Fiorillo E., Smith AM., Restrepo MI., Branum AP., Bottomley MJ., Orrù V., Jimenez F., Carrillo A., Pandranki L., Winter CA., Winter LA., Gaitan AA., Moreira AG., Walter EA., Silvestri G., King CL., Zheng Y-T., Zheng H-Y., Kimani J., Blake Ball T., Plummer FA., Fowke KR., Harden PN., Wood KJ., Ferris MT., Lund JM., Heise MT., Garrett N., Canady KR., Abdool Karim SS., Little SJ., Gianella S., Smith DM., Letendre S., Richman DD., Cucca F., Trinh H., Sanchez-Reilly S., Hecht JM., Cadena Zuluaga JA., Anzueto A., Pugh JA., Abdalla MI., Adams SG., Adebayo Y., Agnew J., Ali S., Anstead G., Balmes M., Barker J., Baruch-Bienen D., Bible V., Birdwell A., Braddy S., Bradford S., Briggs H., Corral JM., Dacus JJ., Danaher PJ., DePaul SA., Dickerson J., Doanne J., Ehsan A., Elbel S., Escalante M., Escamilla C., Escamilla V., Farrar R., Feldman D., Flores D., Flynn J., Ford D., Foy JD., Freeman M., Galley S., Garcia J., Garza M., Gilman S., Goel M., Gomez J., Goyal VK., Grassmuck S., Grigsby S., Hanson J., Harris B., Haywood A., Hinojosa C., Ho TT., Hopkins T., Horvath LL., Hussain AN., Jabur A., Jewell P., Johnson TB., Lawler AC., Lee M., Lester CS., Levine SM., Lewis HV., Louder A., Mainor C., Maldonado R., Martinez C., Martinez Y., Maselli D., Mata C., McElligott N., Medlin L., Mireles M., Moreno J., Morneau K., Muetz J., Munro SB., Murray C., Nambiar A., Nassery D., Nathanson R., Oakman K., O’Rorke J., Padgett C., Pascual-Guardia S., Patterson M., Perez GL., Perez R., Perez R., Phillips RE., Polk PB., Pomager MA., Preston KJ., Proud KC., Rangel M., Ratcliffe TA., Reichelderfer RL., Renz EM., Ross J., Rudd T., Sanchez ME., Sanders T., Schindler KC., Schmit D., Sehgal RT., Solorzano C., Soni N., Tam WS., Tovar EJ., Trammell Velasquez SA., Tyler AR., Vasquez A., Veloso MC., Venticinque SG., Villalpando JA., Villanueva M., Villegas L., Walker M., Wallace A., Wallace M., Wang E., Wickizer S., Williamson A., Yunes A., Zentner KH., Agan BK., Root-Bernstein R., Clark RA., Okulicz JF., He W.

AbstractSome people remain healthier throughout life than others but the underlying reasons are poorly understood. Here we hypothesize this advantage is attributable in part to optimal immune resilience (IR), defined as the capacity to preserve and/or rapidly restore immune functions that promote disease resistance (immunocompetence) and control inflammation in infectious diseases as well as other causes of inflammatory stress. We gauge IR levels with two distinct peripheral blood metrics that quantify the balance between (i) CD8+ and CD4+ T-cell levels and (ii) gene expression signatures tracking longevity-associated immunocompetence and mortality-associated inflammation. Profiles of IR metrics in ~48,500 individuals collectively indicate that some persons resist degradation of IR both during aging and when challenged with varied inflammatory stressors. With this resistance, preservation of optimal IR tracked (i) a lower risk of HIV acquisition, AIDS development, symptomatic influenza infection, and recurrent skin cancer; (ii) survival during COVID-19 and sepsis; and (iii) longevity. IR degradation is potentially reversible by decreasing inflammatory stress. Overall, we show that optimal IR is a trait observed across the age spectrum, more common in females, and aligned with a specific immunocompetence-inflammation balance linked to favorable immunity-dependent health outcomes. IR metrics and mechanisms have utility both as biomarkers for measuring immune health and for improving health outcomes.

Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

DOI

Type

Publisher

Publication Date

Volume